HK Stock MarketDetailed Quotes

AM GROUP (01849)

Watchlist
  • 0.050
  • 0.0000.00%
Not Open May 6 09:20 CST
40.00MMarket Cap-2.94P/E (TTM)

AM GROUP (01849) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Dec 31, 2025
(FY)Jun 30, 2025
(Q6)Dec 31, 2024
(FY)Jun 30, 2024
(Q6)Dec 31, 2023
(FY)Jun 30, 2023
(Q6)Dec 31, 2022
(FY)Jun 30, 2022
(Q6)Dec 31, 2021
(FY)Jun 30, 2021
Turnover
-7.07%12.16M
-30.47%25.07M
-13.54%13.08M
-25.18%36.06M
-36.28%15.13M
-0.04%48.2M
-30.23%23.74M
-11.42%48.22M
135.07%34.03M
120.02%54.44M
Operating income
-7.07%12.16M
-30.47%25.07M
-13.54%13.08M
-25.18%36.06M
-36.28%15.13M
-0.04%48.2M
-30.23%23.74M
-11.42%48.22M
135.07%34.03M
120.02%54.44M
Cost of sales
4.88%-8.81M
32.20%-18.48M
18.65%-9.26M
22.38%-27.25M
33.05%-11.39M
-7.48%-35.11M
24.20%-17.01M
10.57%-32.67M
-118.63%-22.44M
-127.59%-36.53M
Operating expenses
4.88%-8.81M
32.20%-18.48M
18.65%-9.26M
22.38%-27.25M
33.05%-11.39M
-7.48%-35.11M
24.20%-17.01M
10.57%-32.67M
-118.63%-22.44M
-127.59%-36.53M
Gross profit
-12.39%3.34M
-25.12%6.6M
2.03%3.82M
-32.69%8.81M
-44.42%3.74M
-15.82%13.09M
-41.90%6.73M
-13.16%15.55M
175.14%11.59M
106.04%17.91M
Selling expenses
2.62%-521K
2.84%-1.16M
4.63%-535K
10.14%-1.2M
-50.00%-561K
60.49%-1.33M
81.11%-374K
-10.96%-3.37M
-152.87%-1.98M
-178.46%-3.04M
Administrative expenses
-37.62%-4.11M
8.05%-7.47M
14.06%-2.99M
6.95%-8.13M
17.47%-3.48M
-17.49%-8.73M
-26.40%-4.21M
-13.45%-7.43M
-15.57%-3.33M
-38.26%-6.55M
Impairment and provision
148.86%43K
79.02%-575K
-132.84%-88K
14.72%-2.74M
23.50%268K
-46.22%-3.21M
61.94%217K
-88.67%-2.2M
152.14%134K
-47.84%-1.17M
-Goodwill impairment
----
----
----
----
----
----
----
---1.87M
----
----
-Other impairment is provision
148.86%43K
79.02%-575K
-132.84%-88K
14.72%-2.74M
23.50%268K
-882.87%-3.21M
61.94%217K
71.93%-327K
152.14%134K
-47.84%-1.17M
Special items of operating profit
-54.86%79K
-48.10%409K
-35.90%175K
22.93%788K
23.53%273K
103.49%641K
70.00%221K
-90.43%315K
388.89%130K
159.29%3.29M
Operating profit
-406.30%-1.17M
10.59%-2.2M
56.15%381K
-642.73%-2.46M
-90.55%244K
-84.15%454K
-60.50%2.58M
-72.58%2.87M
2,969.01%6.54M
212.41%10.45M
Financing cost
-5.26%-40K
57.49%-71K
45.71%-38K
24.43%-167K
46.15%-70K
-62.50%-221K
-261.11%-130K
-102.99%-136K
---36K
-1.52%-67K
Share of profits of associates
----
----
----
----
----
----
----
----
----
--664K
Special items of earning before tax
----
----
----
---26.12M
----
----
----
----
----
----
Earning before tax
-451.90%-1.21M
92.09%-2.27M
97.13%343K
-12,439.91%-28.75M
-92.90%174K
-91.46%233K
-62.28%2.45M
-75.29%2.73M
566.09%6.5M
236.91%11.04M
Tax
47.78%-200K
23.41%-471K
-16.06%-383K
53.20%-615K
14.95%-330K
-58.70%-1.31M
58.28%-388K
49.01%-828K
-175.15%-930K
-103.76%-1.62M
After-tax profit from continuing operations
-3,417.50%-1.41M
90.65%-2.75M
74.36%-40K
-2,616.65%-29.37M
-107.56%-156K
-156.86%-1.08M
-62.95%2.06M
-79.82%1.9M
773.20%5.57M
279.69%9.42M
Earning after tax
-3,417.50%-1.41M
90.65%-2.75M
74.36%-40K
-2,616.65%-29.37M
-107.56%-156K
-156.86%-1.08M
-62.95%2.06M
-79.82%1.9M
773.20%5.57M
279.69%9.42M
Minority profit
-94.76%117K
-60.13%252K
818.11%2.23M
14.29%632K
-46.71%243K
-30.70%553K
-59.89%456K
-52.73%798K
601.85%1.14M
--1.69M
Profit attributable to shareholders
32.89%-1.52M
90.01%-3M
-469.17%-2.27M
-1,735.92%-30M
-124.81%-399K
-248.14%-1.63M
-63.73%1.61M
-85.73%1.1M
831.51%4.43M
211.65%7.73M
Basic earnings per share
32.14%-0.0019
89.19%-0.004
-460.00%-0.0028
-1,750.00%-0.037
-125.00%-0.0005
-300.00%-0.002
-63.64%0.002
-90.00%0.001
816.67%0.0055
233.33%0.01
Diluted earnings per share
32.14%-0.0019
89.19%-0.004
-460.00%-0.0028
-1,750.00%-0.037
-125.00%-0.0005
-300.00%-0.002
-63.64%0.002
-90.00%0.001
816.67%0.0055
233.33%0.01
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
--
--
--
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
(Q6)Dec 31, 2025(FY)Jun 30, 2025(Q6)Dec 31, 2024(FY)Jun 30, 2024(Q6)Dec 31, 2023(FY)Jun 30, 2023(Q6)Dec 31, 2022(FY)Jun 30, 2022(Q6)Dec 31, 2021(FY)Jun 30, 2021
Turnover -7.07%12.16M-30.47%25.07M-13.54%13.08M-25.18%36.06M-36.28%15.13M-0.04%48.2M-30.23%23.74M-11.42%48.22M135.07%34.03M120.02%54.44M
Operating income -7.07%12.16M-30.47%25.07M-13.54%13.08M-25.18%36.06M-36.28%15.13M-0.04%48.2M-30.23%23.74M-11.42%48.22M135.07%34.03M120.02%54.44M
Cost of sales 4.88%-8.81M32.20%-18.48M18.65%-9.26M22.38%-27.25M33.05%-11.39M-7.48%-35.11M24.20%-17.01M10.57%-32.67M-118.63%-22.44M-127.59%-36.53M
Operating expenses 4.88%-8.81M32.20%-18.48M18.65%-9.26M22.38%-27.25M33.05%-11.39M-7.48%-35.11M24.20%-17.01M10.57%-32.67M-118.63%-22.44M-127.59%-36.53M
Gross profit -12.39%3.34M-25.12%6.6M2.03%3.82M-32.69%8.81M-44.42%3.74M-15.82%13.09M-41.90%6.73M-13.16%15.55M175.14%11.59M106.04%17.91M
Selling expenses 2.62%-521K2.84%-1.16M4.63%-535K10.14%-1.2M-50.00%-561K60.49%-1.33M81.11%-374K-10.96%-3.37M-152.87%-1.98M-178.46%-3.04M
Administrative expenses -37.62%-4.11M8.05%-7.47M14.06%-2.99M6.95%-8.13M17.47%-3.48M-17.49%-8.73M-26.40%-4.21M-13.45%-7.43M-15.57%-3.33M-38.26%-6.55M
Impairment and provision 148.86%43K79.02%-575K-132.84%-88K14.72%-2.74M23.50%268K-46.22%-3.21M61.94%217K-88.67%-2.2M152.14%134K-47.84%-1.17M
-Goodwill impairment -------------------------------1.87M--------
-Other impairment is provision 148.86%43K79.02%-575K-132.84%-88K14.72%-2.74M23.50%268K-882.87%-3.21M61.94%217K71.93%-327K152.14%134K-47.84%-1.17M
Special items of operating profit -54.86%79K-48.10%409K-35.90%175K22.93%788K23.53%273K103.49%641K70.00%221K-90.43%315K388.89%130K159.29%3.29M
Operating profit -406.30%-1.17M10.59%-2.2M56.15%381K-642.73%-2.46M-90.55%244K-84.15%454K-60.50%2.58M-72.58%2.87M2,969.01%6.54M212.41%10.45M
Financing cost -5.26%-40K57.49%-71K45.71%-38K24.43%-167K46.15%-70K-62.50%-221K-261.11%-130K-102.99%-136K---36K-1.52%-67K
Share of profits of associates --------------------------------------664K
Special items of earning before tax ---------------26.12M------------------------
Earning before tax -451.90%-1.21M92.09%-2.27M97.13%343K-12,439.91%-28.75M-92.90%174K-91.46%233K-62.28%2.45M-75.29%2.73M566.09%6.5M236.91%11.04M
Tax 47.78%-200K23.41%-471K-16.06%-383K53.20%-615K14.95%-330K-58.70%-1.31M58.28%-388K49.01%-828K-175.15%-930K-103.76%-1.62M
After-tax profit from continuing operations -3,417.50%-1.41M90.65%-2.75M74.36%-40K-2,616.65%-29.37M-107.56%-156K-156.86%-1.08M-62.95%2.06M-79.82%1.9M773.20%5.57M279.69%9.42M
Earning after tax -3,417.50%-1.41M90.65%-2.75M74.36%-40K-2,616.65%-29.37M-107.56%-156K-156.86%-1.08M-62.95%2.06M-79.82%1.9M773.20%5.57M279.69%9.42M
Minority profit -94.76%117K-60.13%252K818.11%2.23M14.29%632K-46.71%243K-30.70%553K-59.89%456K-52.73%798K601.85%1.14M--1.69M
Profit attributable to shareholders 32.89%-1.52M90.01%-3M-469.17%-2.27M-1,735.92%-30M-124.81%-399K-248.14%-1.63M-63.73%1.61M-85.73%1.1M831.51%4.43M211.65%7.73M
Basic earnings per share 32.14%-0.001989.19%-0.004-460.00%-0.0028-1,750.00%-0.037-125.00%-0.0005-300.00%-0.002-63.64%0.002-90.00%0.001816.67%0.0055233.33%0.01
Diluted earnings per share 32.14%-0.001989.19%-0.004-460.00%-0.0028-1,750.00%-0.037-125.00%-0.0005-300.00%-0.002-63.64%0.002-90.00%0.001816.67%0.0055233.33%0.01
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----------Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor ----------National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More